Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details Narrative)

v3.7.0.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Revenues $ 40,000 $ 20,000
Additional milestone revenue received 50,000  
Research and development $ 352,583 $ 1,423,769
Total dilutive shares
Common Stock Options [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 6,115,480 1,745,480
Common Stock Warrants [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 1,568,845 1,376,538
Conversion of Debentures [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 785,714 2,075,000
Conversion of Notes Payable [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 126,923  
Conversion of Notes Payable - Related Parties [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 413,719  
Conversion of Redeemable Convertible Preferred Stock [Member]    
Antidilutive securities excluded from computation of net loss per share, amount 2,857,142 2,380,952